Modeling of Chronic Lung Inflammation in Rats by Repeated Intratracheal Administration of LPS

Bull Exp Biol Med. 2022 Oct;173(6):790-793. doi: 10.1007/s10517-022-05633-w. Epub 2022 Nov 2.

Abstract

A model of a chronic lung inflammation in SPF Sprague-Dawley rats was developed by repeated intratracheal administration of LPS in a dose of 0.4 mg/kg. On day 22 of the study, male rats treated with LPS have relative monocytopenia and reduced mean concentration of hemoglobin in the erythrocyte and the mean platelet volume in comparison with the control animals (saline). Intratracheal administration of LPS induced an inflammatory process in the lungs characterized by focal atelectasis, compensatory emphysematous expansion of subpleural pulmonary acini, focal mononuclear and neutrophilic perivascular and peribronchial infiltration, and minor focal mononuclear and neutrophilic infiltration of the alveolar walls. Against the background of LPS administration, germinal centers appeared in the lymphoid follicles of the white pulp of the spleen, and focal mononuclear infiltration of the tracheal mucosa and/or submucosa was observed in some animals.

Keywords: LPS; Sprague-Dawley rats; chronic inflammation; in vivo; lipopolysaccharide; lungs.

MeSH terms

  • Animals
  • Lipopolysaccharides* / toxicity
  • Lung
  • Male
  • Pneumonia* / chemically induced
  • Rats
  • Rats, Sprague-Dawley
  • Trachea

Substances

  • Lipopolysaccharides